You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 298 No. 17, November 7, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Cardiovascular Disease/ Myocardial Infarction
 •Genetics
 •Genetics, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

A New Era of Cardiovascular Disease Epidemiology

Bruce M. Psaty, MD, PhD; Donna Arnett, PhD; Gregory Burke, MD, MS

JAMA. 2007;298(17):2060-2062.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Cardiovascular epidemiology has a rich, collaborative, and productive history. Beginning in 1948, the Framingham Heart Study was instrumental in identifying, for instance, high blood pressure and dyslipidemia as major risk factors for coronary heart disease and stroke.1 Subsequent clinical trials identified safe and effective treatments for these conditions. In the last several decades, the widespread use of medications for hypertension and dyslipidemia have prevented or delayed the onset of cardiovascular disease for millions of US residents. At the 60th anniversary of the Framingham study, a new approach to cardiovascular disease epidemiology is about to be tested.

In October 2007, data from approximately 9000 Framingham participants, not only extensive phenotype data but also 500 000 single nucleotide polymorphisms (SNPs) from a whole-genome scan on each individual, became accessible to the scientific community under the SHARe (SNP Health Association Resource) program.2 . . . [Full Text of this Article]

Author Affiliations: Cardiovascular Health Research Unit, Departments of Medicine, Epidemiology and Health Services, University of Washington and Center for Health Studies, Group Health, Seattle (Dr Psaty); Department of Epidemiology, University of Alabama at Birmingham, Birmingham (Dr Arnett); and Division of Public Health Sciences, Wake Forest University, Winston-Salem, North Carolina (Dr Burke).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.